URGN short interest
UroGen Pharma Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 7,766,918 |
|---|---|
| Change vs prior report | 1,519,420 (+24.3%) |
| Change over six months | -7.0% |
| Days to cover | 9.91 (sector: 3.78) |
| Average daily volume | 783,547 |
| Rank in Healthcare | #112 of 922 by days to cover |
URGN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 7,766,918 | +24.3% | 9.91 | 783,547 |
| 2026-09-15 | 6,247,498 | +0.0% | 9.16 | 681,702 |
| 2026-08-31 | 6,245,387 | +22.0% | 6.79 | 919,418 |
| 2026-08-14 | 5,120,407 | +11.6% | 4.80 | 1,066,452 |
| 2026-07-31 | 4,589,109 | -19.3% | 6.64 | 691,634 |
| 2026-07-15 | 5,689,384 | -8.5% | 6.90 | 825,084 |
| 2026-06-30 | 6,218,229 | -5.2% | 9.42 | 660,094 |
| 2026-06-15 | 6,557,146 | -5.3% | 9.87 | 664,053 |
| 2026-05-29 | 6,921,016 | +2.3% | 11.09 | 623,859 |
| 2026-05-15 | 6,764,905 | -6.5% | 5.82 | 1,162,466 |
| 2026-04-30 | 7,236,438 | -7.5% | 8.88 | 814,957 |
| 2026-04-15 | 7,826,923 | -6.2% | 11.19 | 699,218 |
| 2026-03-31 | 8,348,466 | -3.2% | 11.83 | 705,960 |
| 2026-03-13 | 8,629,222 | +7.6% | 7.84 | 1,100,950 |
| 2026-02-27 | 8,018,559 | -14.1% | 10.84 | 739,988 |
| 2026-02-13 | 9,335,645 | -9.3% | 15.12 | 617,235 |
| 2026-01-30 | 10,298,661 | -2.5% | 14.56 | 707,229 |
| 2026-01-15 | 10,568,458 | +10.8% | 14.52 | 727,899 |
| 2025-12-31 | 9,541,727 | +23.3% | 13.54 | 704,774 |
| 2025-12-15 | 7,739,834 | -2.6% | 8.25 | 938,036 |
| 2025-11-28 | 7,950,298 | -11.4% | 7.29 | 1,090,302 |
| 2025-11-14 | 8,976,703 | -20.4% | 5.34 | 1,679,557 |
| 2025-10-31 | 11,283,704 | +1.2% | 13.57 | 831,781 |
| 2025-10-15 | 11,148,494 | +27.9% | 9.95 | 1,120,424 |
| 2025-09-30 | 8,715,101 | +9.7% | 7.32 | 1,190,668 |
import finzdata as yf
yf.Ticker("URGN").short_interest # every report since 2017
yf.Client().short_interest(["URGN"], start="2018-01-01")Healthcare short interest · URGN price history · Who owns URGN · All short interest